VRDN - Viridian Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$36.88
DETAILS
HIGH:
$45.00
LOW:
$26.00
MEDIAN:
$38.50
CONSENSUS:
$36.88
UPSIDE:
96.33%
AlphaQuality
Quantitative six-pillar business-quality grade
Distressed or Transitioning
Ungradable
AlphaQuality does not grade distressed or transitioning companies — their quality is dominated by balance-sheet and capital-structure factors outside the scope of this model.